Please try another search
Period Ending: | 2021 31/12 |
2020 31/12 |
2019 31/12 |
2018 31/12 |
|||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Current Assets | 11935.03 | 13670.01 | 11709.91 | 14188.53 | |||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||
Total Assets | 64797.49 | 86704.94 | 94936.6 | 94373.25 | |||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||
Total Current Liabilities | 20952.45 | 56878.23 | 45732.65 | 40585.28 | |||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||
Total Liabilities | 31082.59 | 63607.68 | 63041.25 | 61455.63 | |||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||
Total Equity | 33714.9 | 23097.26 | 31895.35 | 32917.61 | |||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||
Total Liabilities & Shareholders' Equity | 64797.49 | 86704.94 | 94936.6 | 94373.25 | |||||||||||||||||||||||||||||||||||||||||||||
Total Common Shares Outstanding | 0.23 | 0.24 | 0.24 | 3.53 | |||||||||||||||||||||||||||||||||||||||||||||
Total Preferred Shares Outstanding | 0.02 | 0.33 | 0.33 | 0.33 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review